BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8475405)

  • 1. Targeted drug delivery.
    Leyland-Jones B
    Semin Oncol; 1993 Feb; 20(1):12-7. PubMed ID: 8475405
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour-selective drug delivery via folate receptor-targeted liposomes.
    Pan X; Lee RJ
    Expert Opin Drug Deliv; 2004 Nov; 1(1):7-17. PubMed ID: 16296717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery in cancer using liposomes.
    Dass CR
    Methods Mol Biol; 2008; 437():177-82. PubMed ID: 18369969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.
    Drummond DC; Meyer O; Hong K; Kirpotin DB; Papahadjopoulos D
    Pharmacol Rev; 1999 Dec; 51(4):691-743. PubMed ID: 10581328
    [No Abstract]   [Full Text] [Related]  

  • 5. Dendrimers as carriers for delivery of chemotherapeutic agents.
    Medina SH; El-Sayed ME
    Chem Rev; 2009 Jul; 109(7):3141-57. PubMed ID: 19534493
    [No Abstract]   [Full Text] [Related]  

  • 6. Liposomes for drug targeting in cancer chemotherapy.
    Liliemark J
    Eur J Surg Suppl; 1991 May; (561):49-52. PubMed ID: 1720049
    [No Abstract]   [Full Text] [Related]  

  • 7. Liposomes and cancer therapy.
    Gregoriadis G; Florence AT
    Cancer Cells; 1991 Apr; 3(4):144-6. PubMed ID: 1883687
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate cancer-specific monoclonal antibody 5D4 significantly enhances the cytotoxicity of doxorubicin-loaded liposomes against target cells in vitro.
    Sawant RM; Cohen MB; Torchilin VP; Rokhlin OW
    J Drug Target; 2008 Aug; 16(7):601-4. PubMed ID: 18686131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical mechanisms and methods employed in drug delivery to tumors.
    Besić E
    Acta Pharm; 2007 Sep; 57(3):249-68. PubMed ID: 17878107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Not only anticancer drugs but also enzymes can be encapsulated in either micelle or other carrier for the treatment of cancer.
    Tan Q; Zhang J; Zhang L
    Med Hypotheses; 2010 Feb; 74(2):396-7. PubMed ID: 19762160
    [No Abstract]   [Full Text] [Related]  

  • 11. Nanoparticles for drug delivery in cancer treatment.
    Haley B; Frenkel E
    Urol Oncol; 2008; 26(1):57-64. PubMed ID: 18190833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour-targeted drug and gene delivery: principles and concepts.
    Cassidy J; Schätzlein AG
    Expert Rev Mol Med; 2004 Sep; 6(19):1-17. PubMed ID: 15387893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal cytokines in the treatment of infectious diseases and cancer.
    ten Hagen TL
    Methods Enzymol; 2005; 391():125-45. PubMed ID: 15721378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-sensitive liposomes--principle and application in cancer therapy.
    Karanth H; Murthy RS
    J Pharm Pharmacol; 2007 Apr; 59(4):469-83. PubMed ID: 17430630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug delivery.
    Saito R; Krauze MT; Noble CO; Tamas M; Drummond DC; Kirpotin DB; Berger MS; Park JW; Bankiewicz KS
    J Neurosci Methods; 2006 Jun; 154(1-2):225-32. PubMed ID: 16472868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells.
    Mai J; Song S; Rui M; Liu D; Ding Q; Peng J; Xu Y
    J Control Release; 2009 Nov; 139(3):174-81. PubMed ID: 19576253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the targeted delivery of theranostic carbon nanotubes have potential as a valid anticancer strategy?
    Das M
    Ther Deliv; 2014 Jan; 5(1):1-5. PubMed ID: 24341809
    [No Abstract]   [Full Text] [Related]  

  • 18. Sterically stabilized liposomes in cancer therapy and gene delivery.
    Lasic DD; Vallner JJ; Working PK
    Curr Opin Mol Ther; 1999 Apr; 1(2):177-85. PubMed ID: 11715941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucuronate-modified, long-circulating liposomes for the delivery of anticancer agents.
    Oku N; Namba Y
    Methods Enzymol; 2005; 391():145-62. PubMed ID: 15721379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silk fibroin mediated delivery of liposomal emodin to breast cancer cells.
    Cheema SK; Gobin AS; Rhea R; Lopez-Berestein G; Newman RA; Mathur AB
    Int J Pharm; 2007 Aug; 341(1-2):221-9. PubMed ID: 17499461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.